The US Centers for Medicare and Medicaid Services will allow for Medicare reimbursement of infused or injected Part B drugs administered at home as long as a physician or practitioner is supervising with interactive telecommunications technology, according to an interim final rule released on 30 March.
Entitled “Medicare and Medicaid Programs; Policy and Regulatory Revisions in Response to the COVID-19 Public Health Emergency,” the rule also...







